Trial Profile

A Retrospective, Observational Cohort Study Evaluating the Effectiveness and Cardiovascular Safety of Abaloparatide in Postmenopausal Women New to Anabolic Therapies

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 23 Apr 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Abaloparatide (Primary) ; Teriparatide (Primary)
Indications Postmenopausal osteoporosis
Focus Therapeutic Use
Sponsors Radius Health Inc.

Most Recent Events

23 Oct 2023 Status changed from active, no longer recruiting to completed.
26 Mar 2022 Results of comparative effectiveness and cardiovascular safety of Abaloparatide and Teriparatide in post-menopausal women new to anabolic therapy presented at the 2022 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
13 Aug 2021 Status changed from not yet recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com